Drug Intelligence Revenue
Research Services • 
Toronto, Ontario, Canada • 21-50 Employees
Drug Intelligence revenue & valuation
| Annual revenue | $2,737,760 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $8,800,000 |
| Total funding | No funding |
Key Contacts at Drug Intelligence
Rahim Noormohamed
Chief Executive Officer
Nick Antoniadis
Director Of Client Engagement
Ali Noormohamed
Director, Product
Blaine Mackie
Director, Research & Insights
Aqsa Mian
Director Of Operations
Tazmin Merali
Co Founder And Chief Scientific Officer
Amedu Michael
Business Owner
Company overview
| Headquarters | 251 Consumers Road, Suite 1020, Toronto, Ontario M2J4R3, CA |
| Phone number | +14164988052 |
| Website | |
| NAICS | 5417 |
| SIC | 591 |
| Keywords | Oncology, Immunology, Biologics, Real World Evidence, Specialty Pharmaceuticals, Hospital Pharmaceuticals, Hep-C, Health Treatment Databases |
| Founded | 1992 |
| Employees | 21-50 |
| Socials |
Drug Intelligence Email Formats
Drug Intelligence uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@drugintelligence.com), used 68.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@drugintelligence.com | 68.4% |
{first initial}{last name} | jdoe@drugintelligence.com | 18.4% |
{first initial} | j@drugintelligence.com | 10.5% |
{first name} | john@drugintelligence.com | 2.6% |
About Drug Intelligence
Real-World Evidence (RWE) Data Experts In: Specialty medical treatment databases Detailed market metric reports Retrospective & prospective health outcomes studies Health resource economics studies Prospective health registries Drug Intelligence collects, analyzes & interprets how complex drug treatments are used in the real world, in real-time to inform pharmaceutical industry, physicians, payers and pharmacists. We achieve this by defining and bridging therapeutic data gaps, leveraging meaningful RWE to address treatment adoption, market challenges and secure payer access. What makes DI unique? • The holistic approach: rather than looking any one data point or drug in isolation, we provide meaningful analytics by evaluating the full picture of the disease state and therapeutic use • Proprietary real world, real-time disease treatment databases spanning 20+ years in hospital, specialty clinic and office settings that offer detailed market analytics of drug therapy • Contract Research Organization (CRO) for real-world evidence studies in health outcomes and health resource use (retrospective/prospective data research and health registries) • Clinical and commercial expertise in multiple therapeutic areas • Bilingual (English, French)
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Drug Intelligence has 15 employees across 9 departments.
Departments
Number of employees
Funding Data
Drug Intelligence has never raised funding before.
Drug Intelligence Tech Stack
Discover the technologies and tools that power Drug Intelligence's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Blogs
Japan
Belgium
Germany
United States
Netherlands
ItalyFrequently asked questions
4.8
40,000 users
